Enhertu locks onto HER2 receptors – which are found in some breast cancer cells – and can stop them from growing (Daiichi Sankyo, AstraZeneca via AP) Exhausted, with tumours growing in her ...
China’s Duality Biotherapeutics has filed (PDF) paperwork for a Hong Kong IPO, seeking an undisclosed sum to power a broad pipeline of antibody-drug conjugates toward approval. The filing ...